Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving TolvaptanKiyotaka Uchiyama, Kaori Hayashi, Rina Takahashi et al.|Kidney International Reports|2025Cited by 16
A multi-institutional, observational study of outcomes after catheter placement for peritoneal dialysis in JapanTsutomu Sakurada, Masashi Sakai, Shigeki Kojima et al.|Peritoneal Dialysis International|2023Cited by 11
A multi-center randomized controlled trial to investigate potential effects of exercise therapy on renal function stratified by renal disorders and renal pathology: beneficial or harmful effect in immunoglobulin a nephropathyTakahide Kimura, Kiyotaka Uchiyama, Naoki Washida et al.|Clinical and Experimental Nephrology|2024Cited by 7
Impact of home-based exercise on residual kidney function in patients initiating peritoneal dialysis: A feasibility multicenter randomized controlled trialKiyotaka Uchiyama, Naoki Washida, Seiki Yamada et al.|Peritoneal Dialysis International|2024Cited by 4
Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]Kiyotaka Uchiyama, Kaori Hayashi, Daisuke Kamano et al.|Kidney International Reports|2025Cited by 0